Nalaganje...
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Azithromycin is a potent macrolide antibiotic with poorly understood antiinflammatory properties. Long-term use of azithromycin in patients with chronic inflammatory lung diseases, such as cystic fibrosis (CF), results in improved outcomes. Paradoxically, a recent study reported that azithromycin us...
Shranjeno v:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3163956/ https://ncbi.nlm.nih.gov/pubmed/21804191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI46095 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|